Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

newswire.ca - Innocan Pharma Announces Promising Translational Evidence from a Pain Relief Study of Repeated LPT-CBD Administration in Goats
Innocan Pharma Announces Promising Translational Evidence from a Pain Relief Study of Repeated LPT-CBD Administration in Goats
CNW

Two goats suffering from chronic and disabling painful condition were treated with subcutaneous Synthetic Liposomal Cannabidiol (LPT-CBD, 5 mg/kg) injections every six weeks for 10 months. Throughout the study, serial blood sampling was performed…

benzinga.com - Benzinga Insights - A Look Ahead: Arrowhead Pharma's Earnings Forecast - Arrowhead Pharma (NASDAQ:ARWR)
A Look Ahead: Arrowhead Pharma's Earnings Forecast - Arrowhead Pharma (NASDAQ:ARWR)
Benzinga

Arrowhead Pharma (NASDAQ:) is gearing up to announce its quarterly earnings on Tuesday, 2025-11-25. Here's a quick overview of what investors should know before the release. Analysts are estimating that Arrowhead Pharma will report an earnings per…

jacobin.com - Big Pharma Lobbying Makes Medicine Far More Expensive
Big Pharma Lobbying Makes Medicine Far More Expensive
Jacobin

A year after the pharmaceutical industry's top lobbying group delivered a secret multimillion-dollar donation to congressional Republicans, GOP lawmakers quietly defanged rules lowering the price of life-saving medicines. Weakening these rules…

barchart.com - Jim Van Meerten - The Short-Sellers May Be Right About This Red-Hot Pharma Stock
The Short-Sellers May Be Right About This Red-Hot Pharma Stock
Barchart.com

Palvella Therapeutics (PVLA) is a clinical-stage biopharma stock with no revenue or FDA pipeline. However, the stock has exceptional price momentum with shares up 508% over the past year. PVLA is trading at a new 2-year high and has strong…

dev.to - Newpage Solutions - Top 7 GenAI Usecases in Pharma
Top 7 GenAI Usecases in Pharma
DEV Community

2024 was the year of pilot projects. Pharma companies experimented with GenAI, tested narrow use cases, and debated its potential. In 2025, the conversation has shifted. Leaders are no longer asking if GenAI belongs in life sciences. The question…

thehindubusinessline.com - Sudeep Pharma IPO Day 2: Sees Retail demand, Should you apply?
Sudeep Pharma IPO Day 2: Sees Retail demand, Should you apply?
BusinessLine

Sudeep Pharma Ltd's initial public offering witnessed tepid institutional interest as of 10.33 am on the second day of bidding, with the issue subscribed 2.27 times overall. The ₹895 crore IPO, priced between ₹563-593 per share…

dev.to - Newpage Solutions - Why Most Salesforce Implementations in Pharma Don't Deliver (And How to Avoid the Trap)
Why Most Salesforce Implementations in Pharma Don't Deliver (And How to Avoid the Trap)
DEV Community

Every life sciences leader agrees on one thing: Salesforce should be a game-changer for pharma. On paper, it offers a complete view of HCPs, faster patient engagement, compliant workflows, and insights that help commercial and medical teams move…

pharmaceutical-technology.com - Robert Barrie - Eli Lilly flies the pharma flag in tech-heavy $1tn market cap club
Eli Lilly flies the pharma flag in tech-heavy $1tn market cap club
Pharmaceutical Technology

Eli Lilly's market capitalisation hit the $1tn mark in the past week, becoming the first healthcare company in the world to join the exclusive club dominated by technology companies. Buoyed by unprecedented demand for its weight loss drugs, the US…

standard.co.uk - By Grinne N. Aodha - Reports from Ukraine peace talks 'positive' - Irish foreign affairs minister
Reports from Ukraine peace talks 'positive' - Irish foreign affairs minister
Evening Standard

Get our award-winning daily news email featuring exclusive stories, opinion and expert analysis I would like to be emailed about offers, event and updates from Evening Standard. Read our privacy notice. Feedback from participants in the talks aimed…

rediff.com - Rediff News - Stock markets fall for 2nd day
Stock markets fall for 2nd day
Rediff.com

Benchmark stock indices Sensex and Nifty declined on Monday amid last-minute selling by cautious investors and lack of any major triggers. Paring early gains, the 30-share BSE Sensex declined by 331.21 points or 0.39 per cent to settle at…

globenewswire.com - Alvotech - Alvotech Announces Approval of AVT03, a Biosimilar to Prolia and Xgeva (denosumab) in the European Economic Area
Alvotech Announces Approval of AVT03, a Biosimilar to Prolia and Xgeva (denosumab) in the European Economic Area
GlobeNewswire

REYKJAVIK, ICELAND (November 25, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the European Commission (EC) has…

forbes.com - Trefis Team - Eli Lilly Stock Joins $1 Trillion Club: What Is Happening?
Eli Lilly Stock Joins $1 Trillion Club: What Is Happening?
Forbes

Eli Lilly logo on modern glass office building facade with partly cloudy sky, South San Francisco, California, October 16, 2025. (Photo by Smith Collection/Gado/Getty Images) Eli Lilly's stock (NYSE: LLY) soared nearly 50%, in the past six months…

thehindubusinessline.com - TCS, IndiGo, Tata Motors PV, Infosys, Apollo Micro, M&M, NTPC Green, Lupin, Adani Enterprises, HUDCO, Shilpa Medicare, HG Infra, RVNL, Mobavenue, NBCC, Natco Pharma will be in focus
TCS, IndiGo, Tata Motors PV, Infosys, Apollo Micro, M&M, NTPC Green, Lupin, Adani Enterprises, HUDCO, Shilpa Medicare, HG Infra, RVNL, Mobavenue, NBCC, Natco Pharma will be in focus
BusinessLine

InterGlobe Aviation (IndiGo,) shares are set to be listed as a constituent of the benchmark BSE Sensex index, effective from December 22, according to an official announcement on Friday. Tata Motors Passenger Vehicles Ltd will be dropped from the…

dailymail.co.uk - Andrew Neil - Trump's losing control and MAGA's imploding. Insiders are worried
Trump's losing control and MAGA's imploding. Insiders are worried
Mail Online

Donald Trump and his hitherto devoted, even zealous, cheerleader, Marjorie Taylor Greene, ostensibly fell out over the publication of the Epstein files, an argument she won and he lost. But what really divides them is much deeper than that. Indeed…

prnewswire.com - Alfa Laval - Alfa Laval Capital Markets Day 2025 - strengthening growth and profitability ambitions
Alfa Laval Capital Markets Day 2025 - strengthening growth and profitability ambitions
Cision PR Newswire

On 24 November 2025, Alfa Laval hosted its annual Capital Markets Day, where Group Management presents the company's strategic direction for the coming years, along with updates on financial targets and investments for future profitable growth.

Receive a Daily briefing on Pharma Industry News

Get Started